Secondary Immune Dysfunction: Therapy- Induced Deficiencies
Chapter 14, page 228
Chapter 19, page 381
Epidemiology Chapter 14, page 228 Pathophysiology Chapter 14, page 228
Chapter 19, page 381 Chapter 19, page 381
Interprofessional Management •Medical Management •Surgical Management (when applicable) •Complications •Nursing Management
Chapter 14, page 228
Chapter 19, page 381
Excessive Immune Response Type I Hypersensitivity Reaction: Immediate
Chapter 14, page 228
Chapter 19, page 382
Chapter 14, page 219
Chapter 19, page 384
Epidemiology Chapter 14, page 219 Pathophysiology Chapter 14, page 219 Clinical Manifestations Chapter 14, page 219
Chapter 19, page 384 Chapter 19, page 385 Chapter 19, page 385
Interprofessional Management •Medical Management •Surgical Management (when applicable) •Complications •Nursing Management
Chapter 14, page 219
Chapter 19, page 386
Type II Hypersensitivity Reaction: Cytotoxic Chapter 14, page 221
Chapter 19, page 390 Chapter 19, page 390
Epidemiology Chapter 14, page 221
Pathophysiology and Clinical Manifestations
Chapter 14, page 221
Chapter 19, page 390
Interprofessional Management •Medical Management •Surgical Management (when applicable) •Complications •Nursing Management Type III Hypersensitivity Reaction: Immune Complex
Chapter 14, page 221
Chapter 19, page 392
Chapter 14, page 221
Chapter 19, page 392
Epidemiology Chapter 14, page 221
Chapter 19, page 392
Pathophysiology and Clinical Manifestations
Chapter 14, page 221
Chapter 19, page 392
Interprofessional Management •Medical Management •Surgical Management (when applicable) •Complications •Nursing Management
Chapter 14, page 221
Chapter 19, page 393
Type IV Hypersensitivity Reactions
Chapter 14, page 221
Chapter 19, page 393 Chapter 19, page 393
Epidemiology Chapter 14, page 221
Pathophysiology and Clinical Manifestations Interprofessional Management •Medical Management
Chapter 14, page 221
Chapter 19, page 393
Chapter 14, page 221
Chapter 19, page 393
FADavis.com 14
Powered by FlippingBook